The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth

scientific article published on 01 April 1995

The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ART.1780380415
P698PubMed publication ID7718010

P50authorCaroline GordonQ58049734
P2093author name stringA E Johnson
P A Bacon
R G Palmer
P433issue4
P921main subjectsystemic lupus erythematosusQ1485
P304page(s)551-558
P577publication date1995-04-01
P1433published inArthritis and RheumatismQ23929027
P1476titleThe prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth
P478volume38

Reverse relations

cites work (P2860)
Q34153866A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31
Q31142463A meta-analysis of public microarray data identifies gene regulatory pathways deregulated in peripheral blood mononuclear cells from individuals with Systemic Lupus Erythematosus compared to those without
Q35998808Applying a new generation of genetic maps to understand human inflammatory disease
Q35496923Association analyses confirm five susceptibility loci for systemic lupus erythematosus in the Han Chinese population
Q54231271Association of FAS and FAS ligand genes polymorphism and risk of systemic lupus erythematosus.
Q34064253Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus
Q36528740Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium
Q26778277Belimumab in systemic lupus erythematosus
Q51673006Bronchoalveolar lavage fluid cells in mixed connective tissue disease
Q24793281Chronic arthritis in children and adolescents in two Indian health service user populations
Q38133017Clinical aspects of autoimmune rheumatic diseases
Q38034111Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction
Q36443689Contemporary treatment of systemic lupus erythematosus: an update for clinicians.
Q33813399Contraception for adolescents with lupus.
Q36465492Cross-sectional analysis of adverse outcomes in 1,029 pregnancies of Afro-Caribbean women in Trinidad with and without systemic lupus erythematosus
Q55409997Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapy.
Q24243533Dehydroepiandrosterone for systemic lupus erythematosus
Q24245412Dehydroepiandrosterone for systemic lupus erythematosus
Q29417056Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production
Q34128422Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor
Q38947966Does malarial tolerance, through nitric oxide, explain the low incidence of autoimmune disease in tropical Africa?
Q35567251Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States
Q22255575Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden
Q40065685Epidemiology of systemic lupus erythematosus: capturing the butterfly.
Q37335908European population substructure is associated with mucocutaneous manifestations and autoantibody production in systemic lupus erythematosus
Q82298546Factors associated with major infections in patients with granulomatosis with polyangiitis and systemic lupus erythematosus treated for deep organ involvement
Q24562483Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans
Q34319137Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus
Q28550922Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide
Q46681395HLA DRB1*1503 allelic haplotype predominance and associated immunodysregulation in systemic lupus erythematosus
Q24246699Herbal medicines for systemic lupus erythematosus
Q48022368High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus
Q53116103Hydroxychloroquine use: the potential impact of new ocular screening guidelines.
Q21136392Identification of unique microRNA signature associated with lupus nephritis
Q33368979Immunopathogenesis of SLE.
Q34424638Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study
Q62050411Incidence and prevalence of systemic lupus erythematosus among Arab and Chaldean Americans in southeastern Michigan: the Michigan Lupus Epidemiology and Surveillance Program
Q34156325Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins
Q40935346Interleukin-10 activates heat-shock protein 90beta gene expression
Q59444498Iris heterochromia after vertical squint surgery in a patient with SLE
Q37468127Is it relevant to screen young women hospitalized in psychiatric department for neuropsychiatric systemic lupus erythematosus (NPSLE)?: A prospective study of 100 psychiatric inpatients
Q33670694Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome
Q36683387Low socioeconomic status is associated with cardiovascular risk factors and outcomes in systemic lupus erythematosus
Q26740483Lupus Nephritis: A Different Disease in European Patients?
Q46506546Malaria and macrophage function in Africans: a possible link with autoimmune disease?
Q81609248New therapies for systemic lupus erythematosus
Q39367854Off-label use of rituximab for systemic lupus erythematosus in Europe
Q51573777Pharmacogenetics of cyclophosphamide and CYP2C19 polymorphism in Thai systemic lupus erythematosus.
Q34979215Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus
Q34343779Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program
Q38423234Prevalence and incidence of systemic lupus erythematosus in South Korea
Q37334183Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies
Q89482953Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada
Q39261499Relation of risk of systemic lupus erythematosus to west African admixture in a Caribbean population
Q24806807Risk for rheumatic disease in relation to ethnicity and admixture
Q35876782Selective IgA deficiency in autoimmune diseases
Q30251721Sex differences in the incidence of skin and skin-related diseases in Olmsted County, Minnesota, United States, and a comparison with other rates published worldwide
Q41033561Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease
Q21195423Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
Q24543555Systemic lupus erythematosus
Q84420574Systemic lupus erythematosus
Q75828790Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity
Q36577432Systemic lupus erythematosus--2005 annus mirabilis?
Q50848358Systemic lupus erythematosus.
Q51803434Systemic lupus erythematosus.
Q93193261Systemic lupus erythematosus: Diagnosis and clinical management
Q35873057Systemic lupus erythematosus: lupus nephritis
Q36673286Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease.
Q85360834The Contribution of Meta-Analysis of Genome-Wide Association Studies in Investigating the Genetic Susceptibility to Lupus
Q34212462The epidemiology of autoimmune diseases
Q35148597The epidemiology of systemic lupus erythematosus
Q36245989The genetics of lupus: a functional perspective
Q38074915The humanistic and economic burden of systemic lupus erythematosus : a systematic review
Q36475637The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012.
Q37754520The origin and pathogenic consequences of anti-dsDNA antibodies in systemic lupus erythematosus
Q62111857The polymorphic CYP17 allele is not found with increased frequency in systemic lupus erythematosus
Q40337416The prevalences of some rheumatic diseases in western Turkey: Havsa study
Q28188901Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease
Q28766942Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort
Q42728756Treatment of lupus nephritis
Q24564906Understanding sensitivity and specificity with the right side of the brain
Q33621131Understanding the epidemiology and progression of systemic lupus erythematosus
Q70994785Undiagnosed systemic lupus erythematosus in the community
Q37106120Validation of self-report of rheumatoid arthritis and systemic lupus erythematosus: The Women's Health Initiative.
Q45930178Valuing Trial Designs from a Pharmaceutical Perspective Using Value-Based Pricing.
Q53669523[Pathogenesis and new therapeutic approaches for systemic lupus erythematosus].
Q50691910[Systemic lupus erythematosus in Martinique: an epidemiologic study].

Search more.